This program of research evaluates the performance of commonly used comorbidity measures (Charlson Comorbidity Index, Elixhauser and Multipurpose Australian Comorbidity Scoring System) on the prediction of 30-day and 1‑year mortality, 28 day re-admission, and length of stay in an older hip fracture population.